Lv1
64 积分 2024-06-30 加入
Sacituzumab Govitecan plus Pembrolizumab for Advanced Triple-Negative Breast Cancer
6天前
已完结
Efficacy of administration sequence: Sacituzumab Govitecan and Trastuzumab Deruxtecan in HER2-low metastatic breast cancer
6天前
已完结
Payload Diversification Overcomes Resistance and Guides Sequential Antibody–Drug Conjugate Therapy in Breast Cancer
6天前
已完结
Navigating the clinical progress of antibody-drug conjugates: Emerging opportunities and remaining challenges
13天前
已完结
New payloads drive next-gen antibody-drug conjugates
13天前
已完结
Advances in the management of metastatic gastric cancer: current strategies and emerging therapeutics
26天前
已完结
Gastric Cancer: A Review
26天前
已完结
Emerging trends in the global burden of colorectal cancer
26天前
已完结
The immune microenvironment of colorectal cancer
26天前
已完结
Is There Still Room for Monotherapy in EGFR-Mutated Non-Small Cell Lung Cancer?
1个月前
已完结
皖公网安备34019202002308
